Biotech

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%.

Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this link Key Market Insights         With two approved drugs and close […]

The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%. Read More »

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.” The report features an extensive

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis Read More »

Global Handheld Ultrasound Imaging Devices Market, 2020-2030

To order this detailed 235+ page report, please visit this link Key Inclusions An overview of the current market landscape of the handheld ultrasound imaging devices, providing information on the status of development, application area (abdomen, cardiac, gynecological, pulmonary, urological scanning and others), weight of device, type of transducer array (convex / curved, linear, micro-convex,

Global Handheld Ultrasound Imaging Devices Market, 2020-2030 Read More »

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners

According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability. Further, these devices have proven to be useful in quarantining patients demonstrating symptoms of pleural wall thickening and lung congestion, a characteristic of pneumonia, as well as observed in

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners Read More »

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030

Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices; handheld ultrasound scanners have emerged as a novel solution to cater to the unmet need in this domain. In fact, the demand for handheld ultrasound devices is on a surge amidst the COVID-19 pandemic.

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030 Read More »

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030.

The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes   Roots Analysis has announced the addition of “Global Handheld Ultrasound Imaging Devices Market, 2020-2030” report to its list of offerings.   According to industry

The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030. Read More »

Ophthalmic Drugs Contract Manufacturing Market, 2020-2030

To order this 375+ page report, please visit this link Key Inclusions A detailed review of the ophthalmic drugs contract manufacturing market landscape, featuring a list of over 240 CMOs and analysis based on a number of relevant parameters, such as year of establishment, company size, geographical location, scale of operation (preclinical, pilot, clinical, and

Ophthalmic Drugs Contract Manufacturing Market, 2020-2030 Read More »

240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis.

Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource certain aspects of drug development and production operations to contract service providers. To order this

240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis. Read More »

The ophthalmic drugs contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030

Roots Analysis has done a detailed study on Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities. To order this 375+ page report, which

The ophthalmic drugs contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030 Read More »

The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis

Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages Roots Analysis is pleased to announce the publication of its recent study, titled, “Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients

The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis Read More »